Global Artificial Heart Market

Artificial Heart Comprehensive Study by Type (Ventricular Assist Device (VAD), Total Artificial Heart), Application (Healthcare), End User (Hospitals, Clinics, Research Centers, Others) Players and Region - Global Market Outlook to 2032

Artificial Heart Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Artificial Heart
An Artificial heart is device that replace original heart and it perform like original heart. It can be consider as prosthetic device fixed into the body to substitute the organic mammalian heart. Person can live with artificial heart from a few weeks to more than one year. Risk associated with treatment for artificial heart implementation because it can lead to bleed and infection.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


Artificial heart market is a fragmented market due to the presence of various players. companies are focusing on developing innovative products and solutions to improve quality, enhances and promotes performance. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Artificial Heart market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

SynCardia Systems (United States), BiVACOR (United States), CARMAT (France), Abbott (United States), Cleveland Heart (United States), AbioMed (United States), Jarvik Heart (United States), Cirtec Medical Systems (United States), Thoratec Corporation (United States), Boston Scientific Corporation (United States) and Braile Biomedica (Brazil) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Colibri Heart Valve LLC (United States), Cryolife Inc. (United States), Edwards Lifesciences Corporation (United States), Heart Leaflet Technology (United States), Jenavalve Technology Inc.(Germany) and Leman Cardiovascular (Switzerland).

Segmentation Overview
AMA Research has segmented the market of Global Artificial Heart market by Type (Ventricular Assist Device (VAD) and Total Artificial Heart), Application (Healthcare) and Region.



On the basis of geography, the market of Artificial Heart has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals will boost the Artificial Heart market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Awareness about New Technological Innovations and Government Initiation towards Providing Funds for Treatment of Heart Dieses

Market Growth Drivers:
Rising Mortality Ratio Due To Cardiovascular Diseases, Unhealthy Lifestyle and Undesirable Atmospheric Conditions

Challenges:
Need of Skilled Cardiac Specialist and Threat of Substitution by using Alternative Methods

Restraints:
Expensive Treatment, Risk Associated With Transplant Procedure and Strict Regulatory Approvals

Opportunities:
Increasing Healthcare Infrastructure in Emerging Nations

Market Leaders and their expansionary development strategies
In April 2023, SynCardia Systems, LLC, mechanical heart replacement technology provider merge with Altitude Acquisition Corp and become publicly traded company. After this agreement, altitude renamed to Picard Medical holding INC. this merge helped SynCardia Systems, LLC. to expand its presence in artificial heart market
On 1st August 2018, CARMAT the designer and developer of the world's most advanced total artificial heart project has announced successful transplant of a donor heart in the first international patient implanted with the CARMAT heart in October 2017. and On 29th May 2018, Boston Scientific Europe has launched the HeartLogic™ Heart Failure Diagnostic in Europe. It provides a diagnostic tool that enables proactive heart failure (HF) care.


Key Target Audience
Artificial heart Suppliers, Artificial heart Manufacturers, Research Laboratories, Medical Devices Industries, Medical Institutes, Government Research Centre and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Ventricular Assist Device (VAD)
  • Total Artificial Heart
By Application
  • Healthcare
By End User
  • Hospitals
  • Clinics
  • Research Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Mortality Ratio Due To Cardiovascular Diseases
      • 3.2.2. Unhealthy Lifestyle
      • 3.2.3. Undesirable Atmospheric Conditions
    • 3.3. Market Challenges
      • 3.3.1. Need of Skilled Cardiac Specialist
      • 3.3.2. Threat of Substitution by using Alternative Methods
    • 3.4. Market Trends
      • 3.4.1. Increasing Awareness about New Technological Innovations
      • 3.4.2. Government Initiation towards Providing Funds for Treatment of Heart Dieses
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Heart, by Type, Application, End User and Region (value, volume and price ) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Artificial Heart (Value)
      • 5.2.1. Global Artificial Heart by: Type (Value)
        • 5.2.1.1. Ventricular Assist Device (VAD)
        • 5.2.1.2. Total Artificial Heart
      • 5.2.2. Global Artificial Heart by: Application (Value)
        • 5.2.2.1. Healthcare
      • 5.2.3. Global Artificial Heart by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Research Centers
        • 5.2.3.4. Others
      • 5.2.4. Global Artificial Heart Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Artificial Heart (Volume)
      • 5.3.1. Global Artificial Heart by: Type (Volume)
        • 5.3.1.1. Ventricular Assist Device (VAD)
        • 5.3.1.2. Total Artificial Heart
      • 5.3.2. Global Artificial Heart by: Application (Volume)
        • 5.3.2.1. Healthcare
      • 5.3.3. Global Artificial Heart by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
        • 5.3.3.3. Research Centers
        • 5.3.3.4. Others
      • 5.3.4. Global Artificial Heart Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Artificial Heart (Price)
      • 5.4.1. Global Artificial Heart by: Type (Price)
  • 6. Artificial Heart: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. SynCardia Systems (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BiVACOR (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CARMAT (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cleveland Heart (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AbioMed (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Jarvik Heart (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cirtec Medical Systems (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thoratec Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Boston Scientific Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Braile Biomedica (Brazil)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Artificial Heart Sale, by Type, Application, End User and Region (value, volume and price ) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Artificial Heart (Value)
      • 7.2.1. Global Artificial Heart by: Type (Value)
        • 7.2.1.1. Ventricular Assist Device (VAD)
        • 7.2.1.2. Total Artificial Heart
      • 7.2.2. Global Artificial Heart by: Application (Value)
        • 7.2.2.1. Healthcare
      • 7.2.3. Global Artificial Heart by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Research Centers
        • 7.2.3.4. Others
      • 7.2.4. Global Artificial Heart Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Artificial Heart (Volume)
      • 7.3.1. Global Artificial Heart by: Type (Volume)
        • 7.3.1.1. Ventricular Assist Device (VAD)
        • 7.3.1.2. Total Artificial Heart
      • 7.3.2. Global Artificial Heart by: Application (Volume)
        • 7.3.2.1. Healthcare
      • 7.3.3. Global Artificial Heart by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
        • 7.3.3.3. Research Centers
        • 7.3.3.4. Others
      • 7.3.4. Global Artificial Heart Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Artificial Heart (Price)
      • 7.4.1. Global Artificial Heart by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Heart: by Type(USD Million)
  • Table 2. Artificial Heart Ventricular Assist Device (VAD) , by Region USD Million (2019-2024)
  • Table 3. Artificial Heart Total Artificial Heart , by Region USD Million (2019-2024)
  • Table 4. Artificial Heart: by Application(USD Million)
  • Table 5. Artificial Heart Healthcare , by Region USD Million (2019-2024)
  • Table 6. Artificial Heart: by End User(USD Million)
  • Table 7. Artificial Heart Hospitals , by Region USD Million (2019-2024)
  • Table 8. Artificial Heart Clinics , by Region USD Million (2019-2024)
  • Table 9. Artificial Heart Research Centers , by Region USD Million (2019-2024)
  • Table 10. Artificial Heart Others , by Region USD Million (2019-2024)
  • Table 11. South America Artificial Heart, by Country USD Million (2019-2024)
  • Table 12. South America Artificial Heart, by Type USD Million (2019-2024)
  • Table 13. South America Artificial Heart, by Application USD Million (2019-2024)
  • Table 14. South America Artificial Heart, by End User USD Million (2019-2024)
  • Table 15. Brazil Artificial Heart, by Type USD Million (2019-2024)
  • Table 16. Brazil Artificial Heart, by Application USD Million (2019-2024)
  • Table 17. Brazil Artificial Heart, by End User USD Million (2019-2024)
  • Table 18. Argentina Artificial Heart, by Type USD Million (2019-2024)
  • Table 19. Argentina Artificial Heart, by Application USD Million (2019-2024)
  • Table 20. Argentina Artificial Heart, by End User USD Million (2019-2024)
  • Table 21. Rest of South America Artificial Heart, by Type USD Million (2019-2024)
  • Table 22. Rest of South America Artificial Heart, by Application USD Million (2019-2024)
  • Table 23. Rest of South America Artificial Heart, by End User USD Million (2019-2024)
  • Table 24. Asia Pacific Artificial Heart, by Country USD Million (2019-2024)
  • Table 25. Asia Pacific Artificial Heart, by Type USD Million (2019-2024)
  • Table 26. Asia Pacific Artificial Heart, by Application USD Million (2019-2024)
  • Table 27. Asia Pacific Artificial Heart, by End User USD Million (2019-2024)
  • Table 28. China Artificial Heart, by Type USD Million (2019-2024)
  • Table 29. China Artificial Heart, by Application USD Million (2019-2024)
  • Table 30. China Artificial Heart, by End User USD Million (2019-2024)
  • Table 31. Japan Artificial Heart, by Type USD Million (2019-2024)
  • Table 32. Japan Artificial Heart, by Application USD Million (2019-2024)
  • Table 33. Japan Artificial Heart, by End User USD Million (2019-2024)
  • Table 34. India Artificial Heart, by Type USD Million (2019-2024)
  • Table 35. India Artificial Heart, by Application USD Million (2019-2024)
  • Table 36. India Artificial Heart, by End User USD Million (2019-2024)
  • Table 37. South Korea Artificial Heart, by Type USD Million (2019-2024)
  • Table 38. South Korea Artificial Heart, by Application USD Million (2019-2024)
  • Table 39. South Korea Artificial Heart, by End User USD Million (2019-2024)
  • Table 40. Taiwan Artificial Heart, by Type USD Million (2019-2024)
  • Table 41. Taiwan Artificial Heart, by Application USD Million (2019-2024)
  • Table 42. Taiwan Artificial Heart, by End User USD Million (2019-2024)
  • Table 43. Australia Artificial Heart, by Type USD Million (2019-2024)
  • Table 44. Australia Artificial Heart, by Application USD Million (2019-2024)
  • Table 45. Australia Artificial Heart, by End User USD Million (2019-2024)
  • Table 46. Rest of Asia-Pacific Artificial Heart, by Type USD Million (2019-2024)
  • Table 47. Rest of Asia-Pacific Artificial Heart, by Application USD Million (2019-2024)
  • Table 48. Rest of Asia-Pacific Artificial Heart, by End User USD Million (2019-2024)
  • Table 49. Europe Artificial Heart, by Country USD Million (2019-2024)
  • Table 50. Europe Artificial Heart, by Type USD Million (2019-2024)
  • Table 51. Europe Artificial Heart, by Application USD Million (2019-2024)
  • Table 52. Europe Artificial Heart, by End User USD Million (2019-2024)
  • Table 53. Germany Artificial Heart, by Type USD Million (2019-2024)
  • Table 54. Germany Artificial Heart, by Application USD Million (2019-2024)
  • Table 55. Germany Artificial Heart, by End User USD Million (2019-2024)
  • Table 56. France Artificial Heart, by Type USD Million (2019-2024)
  • Table 57. France Artificial Heart, by Application USD Million (2019-2024)
  • Table 58. France Artificial Heart, by End User USD Million (2019-2024)
  • Table 59. Italy Artificial Heart, by Type USD Million (2019-2024)
  • Table 60. Italy Artificial Heart, by Application USD Million (2019-2024)
  • Table 61. Italy Artificial Heart, by End User USD Million (2019-2024)
  • Table 62. United Kingdom Artificial Heart, by Type USD Million (2019-2024)
  • Table 63. United Kingdom Artificial Heart, by Application USD Million (2019-2024)
  • Table 64. United Kingdom Artificial Heart, by End User USD Million (2019-2024)
  • Table 65. Netherlands Artificial Heart, by Type USD Million (2019-2024)
  • Table 66. Netherlands Artificial Heart, by Application USD Million (2019-2024)
  • Table 67. Netherlands Artificial Heart, by End User USD Million (2019-2024)
  • Table 68. Rest of Europe Artificial Heart, by Type USD Million (2019-2024)
  • Table 69. Rest of Europe Artificial Heart, by Application USD Million (2019-2024)
  • Table 70. Rest of Europe Artificial Heart, by End User USD Million (2019-2024)
  • Table 71. MEA Artificial Heart, by Country USD Million (2019-2024)
  • Table 72. MEA Artificial Heart, by Type USD Million (2019-2024)
  • Table 73. MEA Artificial Heart, by Application USD Million (2019-2024)
  • Table 74. MEA Artificial Heart, by End User USD Million (2019-2024)
  • Table 75. Middle East Artificial Heart, by Type USD Million (2019-2024)
  • Table 76. Middle East Artificial Heart, by Application USD Million (2019-2024)
  • Table 77. Middle East Artificial Heart, by End User USD Million (2019-2024)
  • Table 78. Africa Artificial Heart, by Type USD Million (2019-2024)
  • Table 79. Africa Artificial Heart, by Application USD Million (2019-2024)
  • Table 80. Africa Artificial Heart, by End User USD Million (2019-2024)
  • Table 81. North America Artificial Heart, by Country USD Million (2019-2024)
  • Table 82. North America Artificial Heart, by Type USD Million (2019-2024)
  • Table 83. North America Artificial Heart, by Application USD Million (2019-2024)
  • Table 84. North America Artificial Heart, by End User USD Million (2019-2024)
  • Table 85. United States Artificial Heart, by Type USD Million (2019-2024)
  • Table 86. United States Artificial Heart, by Application USD Million (2019-2024)
  • Table 87. United States Artificial Heart, by End User USD Million (2019-2024)
  • Table 88. Canada Artificial Heart, by Type USD Million (2019-2024)
  • Table 89. Canada Artificial Heart, by Application USD Million (2019-2024)
  • Table 90. Canada Artificial Heart, by End User USD Million (2019-2024)
  • Table 91. Mexico Artificial Heart, by Type USD Million (2019-2024)
  • Table 92. Mexico Artificial Heart, by Application USD Million (2019-2024)
  • Table 93. Mexico Artificial Heart, by End User USD Million (2019-2024)
  • Table 94. Artificial Heart Sales: by Type(K Units)
  • Table 95. Artificial Heart Sales Ventricular Assist Device (VAD) , by Region K Units (2019-2024)
  • Table 96. Artificial Heart Sales Total Artificial Heart , by Region K Units (2019-2024)
  • Table 97. Artificial Heart Sales: by Application(K Units)
  • Table 98. Artificial Heart Sales Healthcare , by Region K Units (2019-2024)
  • Table 99. Artificial Heart Sales: by End User(K Units)
  • Table 100. Artificial Heart Sales Hospitals , by Region K Units (2019-2024)
  • Table 101. Artificial Heart Sales Clinics , by Region K Units (2019-2024)
  • Table 102. Artificial Heart Sales Research Centers , by Region K Units (2019-2024)
  • Table 103. Artificial Heart Sales Others , by Region K Units (2019-2024)
  • Table 104. South America Artificial Heart Sales, by Country K Units (2019-2024)
  • Table 105. South America Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 106. South America Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 107. South America Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 108. Brazil Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 109. Brazil Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 110. Brazil Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 111. Argentina Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 112. Argentina Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 113. Argentina Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 114. Rest of South America Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 115. Rest of South America Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 116. Rest of South America Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 117. Asia Pacific Artificial Heart Sales, by Country K Units (2019-2024)
  • Table 118. Asia Pacific Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 119. Asia Pacific Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 120. Asia Pacific Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 121. China Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 122. China Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 123. China Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 124. Japan Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 125. Japan Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 126. Japan Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 127. India Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 128. India Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 129. India Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 130. South Korea Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 131. South Korea Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 132. South Korea Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 133. Taiwan Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 134. Taiwan Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 135. Taiwan Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 136. Australia Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 137. Australia Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 138. Australia Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 139. Rest of Asia-Pacific Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 140. Rest of Asia-Pacific Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 141. Rest of Asia-Pacific Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 142. Europe Artificial Heart Sales, by Country K Units (2019-2024)
  • Table 143. Europe Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 144. Europe Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 145. Europe Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 146. Germany Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 147. Germany Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 148. Germany Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 149. France Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 150. France Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 151. France Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 152. Italy Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 153. Italy Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 154. Italy Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 155. United Kingdom Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 156. United Kingdom Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 157. United Kingdom Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 158. Netherlands Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 159. Netherlands Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 160. Netherlands Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 161. Rest of Europe Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 162. Rest of Europe Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 163. Rest of Europe Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 164. MEA Artificial Heart Sales, by Country K Units (2019-2024)
  • Table 165. MEA Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 166. MEA Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 167. MEA Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 168. Middle East Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 169. Middle East Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 170. Middle East Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 171. Africa Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 172. Africa Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 173. Africa Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 174. North America Artificial Heart Sales, by Country K Units (2019-2024)
  • Table 175. North America Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 176. North America Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 177. North America Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 178. United States Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 179. United States Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 180. United States Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 181. Canada Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 182. Canada Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 183. Canada Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 184. Mexico Artificial Heart Sales, by Type K Units (2019-2024)
  • Table 185. Mexico Artificial Heart Sales, by Application K Units (2019-2024)
  • Table 186. Mexico Artificial Heart Sales, by End User K Units (2019-2024)
  • Table 187. Artificial Heart: by Type(USD/Units)
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Artificial Heart: by Type(USD Million)
  • Table 200. Artificial Heart Ventricular Assist Device (VAD) , by Region USD Million (2027-2032)
  • Table 201. Artificial Heart Total Artificial Heart , by Region USD Million (2027-2032)
  • Table 202. Artificial Heart: by Application(USD Million)
  • Table 203. Artificial Heart Healthcare , by Region USD Million (2027-2032)
  • Table 204. Artificial Heart: by End User(USD Million)
  • Table 205. Artificial Heart Hospitals , by Region USD Million (2027-2032)
  • Table 206. Artificial Heart Clinics , by Region USD Million (2027-2032)
  • Table 207. Artificial Heart Research Centers , by Region USD Million (2027-2032)
  • Table 208. Artificial Heart Others , by Region USD Million (2027-2032)
  • Table 209. South America Artificial Heart, by Country USD Million (2027-2032)
  • Table 210. South America Artificial Heart, by Type USD Million (2027-2032)
  • Table 211. South America Artificial Heart, by Application USD Million (2027-2032)
  • Table 212. South America Artificial Heart, by End User USD Million (2027-2032)
  • Table 213. Brazil Artificial Heart, by Type USD Million (2027-2032)
  • Table 214. Brazil Artificial Heart, by Application USD Million (2027-2032)
  • Table 215. Brazil Artificial Heart, by End User USD Million (2027-2032)
  • Table 216. Argentina Artificial Heart, by Type USD Million (2027-2032)
  • Table 217. Argentina Artificial Heart, by Application USD Million (2027-2032)
  • Table 218. Argentina Artificial Heart, by End User USD Million (2027-2032)
  • Table 219. Rest of South America Artificial Heart, by Type USD Million (2027-2032)
  • Table 220. Rest of South America Artificial Heart, by Application USD Million (2027-2032)
  • Table 221. Rest of South America Artificial Heart, by End User USD Million (2027-2032)
  • Table 222. Asia Pacific Artificial Heart, by Country USD Million (2027-2032)
  • Table 223. Asia Pacific Artificial Heart, by Type USD Million (2027-2032)
  • Table 224. Asia Pacific Artificial Heart, by Application USD Million (2027-2032)
  • Table 225. Asia Pacific Artificial Heart, by End User USD Million (2027-2032)
  • Table 226. China Artificial Heart, by Type USD Million (2027-2032)
  • Table 227. China Artificial Heart, by Application USD Million (2027-2032)
  • Table 228. China Artificial Heart, by End User USD Million (2027-2032)
  • Table 229. Japan Artificial Heart, by Type USD Million (2027-2032)
  • Table 230. Japan Artificial Heart, by Application USD Million (2027-2032)
  • Table 231. Japan Artificial Heart, by End User USD Million (2027-2032)
  • Table 232. India Artificial Heart, by Type USD Million (2027-2032)
  • Table 233. India Artificial Heart, by Application USD Million (2027-2032)
  • Table 234. India Artificial Heart, by End User USD Million (2027-2032)
  • Table 235. South Korea Artificial Heart, by Type USD Million (2027-2032)
  • Table 236. South Korea Artificial Heart, by Application USD Million (2027-2032)
  • Table 237. South Korea Artificial Heart, by End User USD Million (2027-2032)
  • Table 238. Taiwan Artificial Heart, by Type USD Million (2027-2032)
  • Table 239. Taiwan Artificial Heart, by Application USD Million (2027-2032)
  • Table 240. Taiwan Artificial Heart, by End User USD Million (2027-2032)
  • Table 241. Australia Artificial Heart, by Type USD Million (2027-2032)
  • Table 242. Australia Artificial Heart, by Application USD Million (2027-2032)
  • Table 243. Australia Artificial Heart, by End User USD Million (2027-2032)
  • Table 244. Rest of Asia-Pacific Artificial Heart, by Type USD Million (2027-2032)
  • Table 245. Rest of Asia-Pacific Artificial Heart, by Application USD Million (2027-2032)
  • Table 246. Rest of Asia-Pacific Artificial Heart, by End User USD Million (2027-2032)
  • Table 247. Europe Artificial Heart, by Country USD Million (2027-2032)
  • Table 248. Europe Artificial Heart, by Type USD Million (2027-2032)
  • Table 249. Europe Artificial Heart, by Application USD Million (2027-2032)
  • Table 250. Europe Artificial Heart, by End User USD Million (2027-2032)
  • Table 251. Germany Artificial Heart, by Type USD Million (2027-2032)
  • Table 252. Germany Artificial Heart, by Application USD Million (2027-2032)
  • Table 253. Germany Artificial Heart, by End User USD Million (2027-2032)
  • Table 254. France Artificial Heart, by Type USD Million (2027-2032)
  • Table 255. France Artificial Heart, by Application USD Million (2027-2032)
  • Table 256. France Artificial Heart, by End User USD Million (2027-2032)
  • Table 257. Italy Artificial Heart, by Type USD Million (2027-2032)
  • Table 258. Italy Artificial Heart, by Application USD Million (2027-2032)
  • Table 259. Italy Artificial Heart, by End User USD Million (2027-2032)
  • Table 260. United Kingdom Artificial Heart, by Type USD Million (2027-2032)
  • Table 261. United Kingdom Artificial Heart, by Application USD Million (2027-2032)
  • Table 262. United Kingdom Artificial Heart, by End User USD Million (2027-2032)
  • Table 263. Netherlands Artificial Heart, by Type USD Million (2027-2032)
  • Table 264. Netherlands Artificial Heart, by Application USD Million (2027-2032)
  • Table 265. Netherlands Artificial Heart, by End User USD Million (2027-2032)
  • Table 266. Rest of Europe Artificial Heart, by Type USD Million (2027-2032)
  • Table 267. Rest of Europe Artificial Heart, by Application USD Million (2027-2032)
  • Table 268. Rest of Europe Artificial Heart, by End User USD Million (2027-2032)
  • Table 269. MEA Artificial Heart, by Country USD Million (2027-2032)
  • Table 270. MEA Artificial Heart, by Type USD Million (2027-2032)
  • Table 271. MEA Artificial Heart, by Application USD Million (2027-2032)
  • Table 272. MEA Artificial Heart, by End User USD Million (2027-2032)
  • Table 273. Middle East Artificial Heart, by Type USD Million (2027-2032)
  • Table 274. Middle East Artificial Heart, by Application USD Million (2027-2032)
  • Table 275. Middle East Artificial Heart, by End User USD Million (2027-2032)
  • Table 276. Africa Artificial Heart, by Type USD Million (2027-2032)
  • Table 277. Africa Artificial Heart, by Application USD Million (2027-2032)
  • Table 278. Africa Artificial Heart, by End User USD Million (2027-2032)
  • Table 279. North America Artificial Heart, by Country USD Million (2027-2032)
  • Table 280. North America Artificial Heart, by Type USD Million (2027-2032)
  • Table 281. North America Artificial Heart, by Application USD Million (2027-2032)
  • Table 282. North America Artificial Heart, by End User USD Million (2027-2032)
  • Table 283. United States Artificial Heart, by Type USD Million (2027-2032)
  • Table 284. United States Artificial Heart, by Application USD Million (2027-2032)
  • Table 285. United States Artificial Heart, by End User USD Million (2027-2032)
  • Table 286. Canada Artificial Heart, by Type USD Million (2027-2032)
  • Table 287. Canada Artificial Heart, by Application USD Million (2027-2032)
  • Table 288. Canada Artificial Heart, by End User USD Million (2027-2032)
  • Table 289. Mexico Artificial Heart, by Type USD Million (2027-2032)
  • Table 290. Mexico Artificial Heart, by Application USD Million (2027-2032)
  • Table 291. Mexico Artificial Heart, by End User USD Million (2027-2032)
  • Table 292. Artificial Heart Sales: by Type(K Units)
  • Table 293. Artificial Heart Sales Ventricular Assist Device (VAD) , by Region K Units (2027-2032)
  • Table 294. Artificial Heart Sales Total Artificial Heart , by Region K Units (2027-2032)
  • Table 295. Artificial Heart Sales: by Application(K Units)
  • Table 296. Artificial Heart Sales Healthcare , by Region K Units (2027-2032)
  • Table 297. Artificial Heart Sales: by End User(K Units)
  • Table 298. Artificial Heart Sales Hospitals , by Region K Units (2027-2032)
  • Table 299. Artificial Heart Sales Clinics , by Region K Units (2027-2032)
  • Table 300. Artificial Heart Sales Research Centers , by Region K Units (2027-2032)
  • Table 301. Artificial Heart Sales Others , by Region K Units (2027-2032)
  • Table 302. South America Artificial Heart Sales, by Country K Units (2027-2032)
  • Table 303. South America Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 304. South America Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 305. South America Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 306. Brazil Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 307. Brazil Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 308. Brazil Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 309. Argentina Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 310. Argentina Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 311. Argentina Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 312. Rest of South America Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 313. Rest of South America Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 314. Rest of South America Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 315. Asia Pacific Artificial Heart Sales, by Country K Units (2027-2032)
  • Table 316. Asia Pacific Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 317. Asia Pacific Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 318. Asia Pacific Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 319. China Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 320. China Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 321. China Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 322. Japan Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 323. Japan Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 324. Japan Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 325. India Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 326. India Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 327. India Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 328. South Korea Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 329. South Korea Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 330. South Korea Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 331. Taiwan Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 332. Taiwan Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 333. Taiwan Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 334. Australia Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 335. Australia Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 336. Australia Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 337. Rest of Asia-Pacific Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 338. Rest of Asia-Pacific Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 339. Rest of Asia-Pacific Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 340. Europe Artificial Heart Sales, by Country K Units (2027-2032)
  • Table 341. Europe Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 342. Europe Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 343. Europe Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 344. Germany Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 345. Germany Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 346. Germany Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 347. France Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 348. France Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 349. France Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 350. Italy Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 351. Italy Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 352. Italy Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 353. United Kingdom Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 354. United Kingdom Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 355. United Kingdom Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 356. Netherlands Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 357. Netherlands Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 358. Netherlands Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 359. Rest of Europe Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 360. Rest of Europe Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 361. Rest of Europe Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 362. MEA Artificial Heart Sales, by Country K Units (2027-2032)
  • Table 363. MEA Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 364. MEA Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 365. MEA Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 366. Middle East Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 367. Middle East Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 368. Middle East Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 369. Africa Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 370. Africa Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 371. Africa Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 372. North America Artificial Heart Sales, by Country K Units (2027-2032)
  • Table 373. North America Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 374. North America Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 375. North America Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 376. United States Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 377. United States Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 378. United States Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 379. Canada Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 380. Canada Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 381. Canada Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 382. Mexico Artificial Heart Sales, by Type K Units (2027-2032)
  • Table 383. Mexico Artificial Heart Sales, by Application K Units (2027-2032)
  • Table 384. Mexico Artificial Heart Sales, by End User K Units (2027-2032)
  • Table 385. Artificial Heart: by Type(USD/Units)
  • Table 386. Research Programs/Design for This Report
  • Table 387. Key Data Information from Secondary Sources
  • Table 388. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Heart: by Type USD Million (2019-2024)
  • Figure 5. Global Artificial Heart: by Application USD Million (2019-2024)
  • Figure 6. Global Artificial Heart: by End User USD Million (2019-2024)
  • Figure 7. South America Artificial Heart Share (%), by Country
  • Figure 8. Asia Pacific Artificial Heart Share (%), by Country
  • Figure 9. Europe Artificial Heart Share (%), by Country
  • Figure 10. MEA Artificial Heart Share (%), by Country
  • Figure 11. North America Artificial Heart Share (%), by Country
  • Figure 12. Global Artificial Heart: by Type K Units (2019-2024)
  • Figure 13. Global Artificial Heart: by Application K Units (2019-2024)
  • Figure 14. Global Artificial Heart: by End User K Units (2019-2024)
  • Figure 15. South America Artificial Heart Share (%), by Country
  • Figure 16. Asia Pacific Artificial Heart Share (%), by Country
  • Figure 17. Europe Artificial Heart Share (%), by Country
  • Figure 18. MEA Artificial Heart Share (%), by Country
  • Figure 19. North America Artificial Heart Share (%), by Country
  • Figure 20. Global Artificial Heart: by Type USD/Units (2019-2024)
  • Figure 21. Global Artificial Heart share by Players 2024 (%)
  • Figure 22. Global Artificial Heart share by Players (Top 3) 2024(%)
  • Figure 23. Global Artificial Heart share by Players (Top 5) 2024(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. SynCardia Systems (United States) Revenue, Net Income and Gross profit
  • Figure 26. SynCardia Systems (United States) Revenue: by Geography 2024
  • Figure 27. BiVACOR (United States) Revenue, Net Income and Gross profit
  • Figure 28. BiVACOR (United States) Revenue: by Geography 2024
  • Figure 29. CARMAT (France) Revenue, Net Income and Gross profit
  • Figure 30. CARMAT (France) Revenue: by Geography 2024
  • Figure 31. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abbott (United States) Revenue: by Geography 2024
  • Figure 33. Cleveland Heart (United States) Revenue, Net Income and Gross profit
  • Figure 34. Cleveland Heart (United States) Revenue: by Geography 2024
  • Figure 35. AbioMed (United States) Revenue, Net Income and Gross profit
  • Figure 36. AbioMed (United States) Revenue: by Geography 2024
  • Figure 37. Jarvik Heart (United States) Revenue, Net Income and Gross profit
  • Figure 38. Jarvik Heart (United States) Revenue: by Geography 2024
  • Figure 39. Cirtec Medical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 40. Cirtec Medical Systems (United States) Revenue: by Geography 2024
  • Figure 41. Thoratec Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. Thoratec Corporation (United States) Revenue: by Geography 2024
  • Figure 43. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 44. Boston Scientific Corporation (United States) Revenue: by Geography 2024
  • Figure 45. Braile Biomedica (Brazil) Revenue, Net Income and Gross profit
  • Figure 46. Braile Biomedica (Brazil) Revenue: by Geography 2024
  • Figure 47. Global Artificial Heart: by Type USD Million (2027-2032)
  • Figure 48. Global Artificial Heart: by Application USD Million (2027-2032)
  • Figure 49. Global Artificial Heart: by End User USD Million (2027-2032)
  • Figure 50. South America Artificial Heart Share (%), by Country
  • Figure 51. Asia Pacific Artificial Heart Share (%), by Country
  • Figure 52. Europe Artificial Heart Share (%), by Country
  • Figure 53. MEA Artificial Heart Share (%), by Country
  • Figure 54. North America Artificial Heart Share (%), by Country
  • Figure 55. Global Artificial Heart: by Type K Units (2027-2032)
  • Figure 56. Global Artificial Heart: by Application K Units (2027-2032)
  • Figure 57. Global Artificial Heart: by End User K Units (2027-2032)
  • Figure 58. South America Artificial Heart Share (%), by Country
  • Figure 59. Asia Pacific Artificial Heart Share (%), by Country
  • Figure 60. Europe Artificial Heart Share (%), by Country
  • Figure 61. MEA Artificial Heart Share (%), by Country
  • Figure 62. North America Artificial Heart Share (%), by Country
  • Figure 63. Global Artificial Heart: by Type USD/Units (2027-2032)
List of companies from research coverage that are profiled in the study
  • SynCardia Systems (United States)
  • BiVACOR (United States)
  • CARMAT (France)
  • Abbott (United States)
  • Cleveland Heart (United States)
  • AbioMed (United States)
  • Jarvik Heart (United States)
  • Cirtec Medical Systems (United States)
  • Thoratec Corporation (United States)
  • Boston Scientific Corporation (United States)
  • Braile Biomedica (Brazil)
Additional players considered in the study are as follows:
Colibri Heart Valve LLC (United States) , Cryolife Inc. (United States) , Edwards Lifesciences Corporation (United States) , Heart Leaflet Technology (United States) , Jenavalve Technology Inc.(Germany) , Leman Cardiovascular (Switzerland)
Select User Access Type

Key Highlights of Report


Apr 2023 218 Pages 86 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Artificial Heart Market Quantitative research analysis
Global Artificial Heart Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as SynCardia Systems (United States), BiVACOR (United States), CARMAT (France), Abbott (United States), Cleveland Heart (United States), AbioMed (United States), Jarvik Heart (United States), Cirtec Medical Systems (United States), Thoratec Corporation (United States), Boston Scientific Corporation (United States) and Braile Biomedica (Brazil) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Awareness about New Technological Innovations " is seen as one of major influencing trends for Artificial Heart Market during projected period 2024-2032.
The Artificial Heart market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Artificial Heart Market Report?

Have a Query? Click Here

Other Related Reports

Dental Fitting Comprehensive Study by Type (Dentures, Archwires, Anchorage appliances, Braces, Crowns and Bridges, Others), Application (Repair Broken Teeth, Implanted Teeth, Other), Material (Cerami...
$ 3350
Medical Centrifuge Comprehensive Study by Type (Microcentrifuges, Ultracentrifuges), Application (Microbiology, Diagnostics, Genomics, Proteomics, Cellomics, Blood Component Separation), Model (Bench...
$ 3650
Blood Viscometer Comprehensive Study by Type (Rotational Viscometer, Capillary Viscometer), Application (Hospital, Clinic, Laboratory) Players and Region - Global Market Outlook to 2026
$ 3500
HbA1c Testing Device Comprehensive Study by Type (Handheld Device, Bench-top Device), Application (Hospital, Homecare, Diagnostic laboratory, Research Institutions), Technology (Ion-exchange HPLC, En...
$ 3450
Nasal Spray Comprehensive Study by Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution, Saline Nasal Spray, Others), Application (Asthma, Nasal Congestion, Allergic and Non-Aller...
$ 3750
Medical Loupes Comprehensive Study by Application (Dental Clinics, Hospitals, Other) Players and Region - Global Market Outlook to 2026
$ 3500